Optometric Follow-up After Cataract Surgery

Sponsor
Queen's University, Belfast (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04163926
Collaborator
Belfast Health and Social Care Trust (Other), Southern Health and Social Care Trust (Other)
160
2
7

Study Details

Study Description

Brief Summary

This study will investigate the effectiveness of an optometric follow up of cataract surgery versus an ophthalmic surgeon follow up. It will investigate patient satisfaction,safety and cost.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Intervention Group cataract follow up
  • Procedure: Usual Care consultant follow up
N/A

Detailed Description

The study will be a mixed-methods study, including a randomized controlled trial in which participants are randomized after cataract surgery to follow up to be consultant led follow up or conducted by a trained optometrist 4-6 weeks following surgery. All participants will then return 6 months after surgery for an additional follow-up visit with an ophthalmologist other than the operating surgeon with patient healthcare satisfaction (main outcome), cost-effectiveness and safety outcomes being measured. A subset of patients and local clinicians will also take part in a one-time, individual, semi-structured interview.

This research will test an alternative model of aftercare for cataract surgeries, which may reduce patient waiting time and inconvenience. In turn, this could help improve patient satisfaction and reduce costs for both patients and the National Health Service (NHS).

Participants will be recruited by operating surgeons. The research will take place in the hospital/clinic/optometrists' offices.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomised control trial (RCT) control versus usual careRandomised control trial (RCT) control versus usual care
Masking:
Single (Outcomes Assessor)
Masking Description:
Outcome assessor will not know the study group assignment of participants.
Primary Purpose:
Health Services Research
Official Title:
Optometric Versus Ophthalmic Follow up of Cataract Surgery Patients in Northern Ireland: A Mixed Methods Study
Anticipated Study Start Date :
Feb 28, 2022
Anticipated Primary Completion Date :
Aug 30, 2022
Anticipated Study Completion Date :
Sep 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group - Post op follow up by trained optometrist

Intervention group will have cataract follow up conducted by a trained optometrist 4-6 weeks after surgery in community clinic

Procedure: Intervention Group cataract follow up
Intervention group will have cataract follow up conducted by the referring optometrist 4-6 weeks after surgery

Active Comparator: Usual care group - Consultant led post op follow up

Follow-up at 4-6 weeks after surgery led by consultant ophthalmologist

Procedure: Usual Care consultant follow up
Usual care group - Consultant led post op follow up

Outcome Measures

Primary Outcome Measures

  1. Patient Satisfaction following different follow up to cataract surgery (Opthalmic led versus optometric follow up) [At 6 months]

    Patient satisfaction will be measured using the patient satisfaction questionnaire (PSQ)-18 at 6 months after surgery The scale include values for general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with doctor and accessibility and convenience. Each question is scored between 1 - 5. As some questions have reverse scoring (higher values indicate dissatisfaction) scores are reversed so a 5 will show highest satisfaction and 1 show lowest satisfaction. Each item within the subscales will be averaged and results will be given for each of the 7 subscales

Secondary Outcome Measures

  1. Cost [At 6 months]

    The total cost per patient visit will be determined and compared

  2. Patient safety [At 6 months]

    Patient safety outcomes in the operative eye will include: loss of visual acuity >=2 lines Intraocular pressure (IOP) rise >=8 millimetres of mercury (mmHg) post-operative complications as documented by the examining ophthalmologist.

  3. Intraocular pressure (IOP) rise [6 months]

    IOP rise will be compared between the 2 groups in mmHg

  4. Visual Acuity [6 months]

    Visual acuity will be compared between the 2 groups

  5. Post operative complications [6 months]

    Post operative complications will be assessed qualitatively. Surgeons at the 6 month follow up will detail if cornea deep and quiet, wound is intact, intraocular lens centred, posterior capsule intact and clear, anterior vitreous quiet, posterior pole and retina remarkable, signs if infection, retained ens matter and other abnormalities recorded by the surgeon.

Other Outcome Measures

  1. Adherence [At 6 months]

    How well patients that have had cataract surgery follow advice for at home care (use of post-operative medication, self-report) and attending follow up medical appointments (as per patient records) will also be compared between the two groups.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing cataract surgery in 1st or 2nd eye for age-related cataract, in the Belfast Trust and Southern Trust

  • Willing to participate and give informed consent.

Exclusion Criteria:
  • Patients judged by operative surgeon to be of high risk of loss of visual acuity in the operative eye (e.g. end stage glaucoma etc.). Note that patients with ocular comorbidity and previous surgery will not be routinely excluded, nor will monocular patients.

  • Patients that were not referred by an optometrist.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Queen's University, Belfast
  • Belfast Health and Social Care Trust
  • Southern Health and Social Care Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nathan Congdon, Chief Investigator, Queen's University, Belfast
ClinicalTrials.gov Identifier:
NCT04163926
Other Study ID Numbers:
  • B17/29
First Posted:
Nov 15, 2019
Last Update Posted:
Dec 7, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nathan Congdon, Chief Investigator, Queen's University, Belfast
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 7, 2021